Kishore Lakshman is an Endocrinology/Metabolic physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 18 publications with 2,819 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
289 Pleasant St
Suite 604
Fall River, MA 027213005
Telephone
508-646-7710Registry record last updated 9 Jun 2010.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Verity Pharmaceuticals Inc.Program year20252 payments
- Novo Nordisk IncProgram year20257 payments
- Abbott LaboratoriesProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.6%Insulin Analog11.4%Lantus Solostar25%Humalog Kwikpen U-10013%Tresiba Flextouch U-10011%Tresiba Flextouch U-20011%Novolog Flexpen8%Basaglar Kwikpen U-1008%Insulin Lispro Kwikpen U-1008%Admelog Solostar5%Levemir Flexpen4%Toujeo Solostar3%Fiasp Flextouch3%Part D<11 patientsGLP-1 receptor agonist8.6%Ozempic50%Trulicity25%Mounjaro17%Rybelsus7%Part D<11 patients+ 8 more classes in this area
Genitourinary & hormones
32%Androgen28.4%Testosterone Cypionate81%Testosterone17%Xyosted3%Part D<11 patientsEstrogen2.8%Estradiol85%Estradiol (Twice Weekly)15%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
21.9%l-Thyroxine19.2%Levothyroxine Sodium85%Synthroid12%Tirosint3%Part D<11 patientsThyroid Hormone Synthesis Inhibitor1.9%Methimazole100%Part D≥14 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”